{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T10:26:46Z","timestamp":1769250406795,"version":"3.49.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T00:00:00Z","timestamp":1691539200000},"content-version":"am","delay-in-days":312,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["16K15424"],"award-info":[{"award-number":["16K15424"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["21K19478"],"award-info":[{"award-number":["21K19478"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["25670370"],"award-info":[{"award-number":["25670370"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.bbrc.2022.07.117","type":"journal-article","created":{"date-parts":[[2022,8,2]],"date-time":"2022-08-02T20:45:26Z","timestamp":1659473126000},"page":"116-121","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Effects of a selective PPAR\u03b1 modulator, sodium-glucose cotransporter 2 inhibitor, and statin on the myocardial morphology of medaka nonalcoholic fatty liver disease model"],"prefix":"10.1016","volume":"625","author":[{"given":"Marina","family":"Ohkoshi-Yamada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7182-4400","authenticated-orcid":false,"given":"Kenya","family":"Kamimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuto","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Itsuo","family":"Nagayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunta","family":"Yakubo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Abe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7138-1785","authenticated-orcid":false,"given":"Takeshi","family":"Yokoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Sakamaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroteru","family":"Kamimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuji","family":"Terai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2022.07.117_bib1","article-title":"Non-alcoholic fatty liver disease: current global burden","author":"El-Kassas","year":"2022","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.bbrc.2022.07.117_bib2","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","article-title":"Mechanisms and disease consequences of nonalcoholic fatty liver disease","volume":"184","author":"Loomba","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2022.07.117_bib3","doi-asserted-by":"crossref","first-page":"154170","DOI":"10.1016\/j.metabol.2020.154170","article-title":"Complications, morbidity and mortality of nonalcoholic fatty liver disease","volume":"111S","author":"Mantovani","year":"2020","journal-title":"Metabolism"},{"key":"10.1016\/j.bbrc.2022.07.117_bib4","doi-asserted-by":"crossref","first-page":"3541","DOI":"10.2337\/diabetes.54.12.3541","article-title":"Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients","volume":"54","author":"Targher","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.bbrc.2022.07.117_bib5","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1007\/s10620-016-4040-6","article-title":"Cardiovascular disease and myocardial abnormalities in nonalcoholic fatty liver disease","volume":"61","author":"Mantovani","year":"2016","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.bbrc.2022.07.117_bib6","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/oby.21879","article-title":"Nonalcoholic steatohepatitis is associated with cardiac remodeling and dysfunction","volume":"25","author":"Simon","year":"2017","journal-title":"Obesity"},{"key":"10.1016\/j.bbrc.2022.07.117_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0235362","article-title":"A\u00a0novel selective PPAR\u03b1 modulator, pemafibrate promotes ischemia-induced revascularization through the eNOS-dependent mechanisms","volume":"15","author":"Kawanishi","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2022.07.117_bib8","doi-asserted-by":"crossref","first-page":"42477","DOI":"10.1038\/srep42477","article-title":"Pemafibrate, a novel selective peroxisome proliferator-activated receptor alpha modulator, improves the pathogenesis in a rodent model of nonalcoholic steatohepatitis","volume":"7","author":"Honda","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2022.07.117_bib9","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1111\/apt.16596","article-title":"Randomised clinical trial: pemafibrate, a novel selective peroxisome proliferator-activated receptor \u03b1 modulator (SPPARM\u03b1), versus placebo in patients with non-alcoholic fatty liver disease","volume":"54","author":"Nakajima","year":"2021","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.bbrc.2022.07.117_bib10","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/apt.17046","article-title":"Review article: vascular effects of PPARs in the context of NASH","volume":"56","author":"Guix\u00e9-Muntet","year":"2022","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.bbrc.2022.07.117_bib11","doi-asserted-by":"crossref","DOI":"10.1177\/2040622320974833","article-title":"Empagliflozin improves chronic hypercortisolism-induced abnormal myocardial structure and cardiac function in mice","volume":"11","author":"Zhang","year":"2020","journal-title":"Ther. Adv. Chronic Dis."},{"key":"10.1016\/j.bbrc.2022.07.117_bib12","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1056\/NEJMoa1611925","article-title":"CANVAS program collaborative group, canagliflozin and cardiovascular and renal events in type 2 diabetes","volume":"377","author":"Neal","year":"2017","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.bbrc.2022.07.117_bib13","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2020-001990","article-title":"Comparing the effects of tofogliflozin and pioglitazone in non-alcoholic fatty liver disease patients with type 2 diabetes mellitus (ToPiND study): a randomized prospective open-label controlled trial","volume":"9","author":"Yoneda","year":"2021","journal-title":"BMJ Open Diabetes Res. Care."},{"key":"10.1016\/j.bbrc.2022.07.117_bib14","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1007\/s00125-018-4678-z","article-title":"SGLT2 inhibitors: the future for treatment of type 2 diabetes mellitus and other chronic diseases","volume":"61","author":"Wanner","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbrc.2022.07.117_bib15","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.cgh.2021.03.031","article-title":"Prevalence and factors associated with statin use Among patients with nonalcoholic fatty liver disease in the TARGET-NASH study","volume":"20","author":"Thomson","year":"2022","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbrc.2022.07.117_bib16","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/j.1872-034X.2011.00849.x","article-title":"Efficacy of pitavastatin for the treatment of non-alcoholic steatohepatitis with dyslipidemia: an open-label, pilot study","volume":"41","author":"Hyogo","year":"2011","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.bbrc.2022.07.117_bib17","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.bbrc.2018.01.057","article-title":"Effect of histidine on sorafenib-induced vascular damage: analysis using novel medaka fish model","volume":"496","author":"Shinagawa-Kobayashi","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2022.07.117_bib18","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/2211-5463.12598","article-title":"Inhibition of sodium glucose cotransporter 2 (SGLT2) delays liver fibrosis in a medaka model of nonalcoholic steatohepatitis (NASH)","volume":"9","author":"Goto","year":"2019","journal-title":"FEBS Open Bio"},{"key":"10.1016\/j.bbrc.2022.07.117_bib19","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1002\/2211-5463.12734","article-title":"Inhibition of sodium-glucose cotransporter 2 ameliorates renal injury in a novel medaka model of nonalcoholic steatohepatitis-related kidney disease","volume":"9","author":"Nagoya","year":"2019","journal-title":"FEBS Open Bio"},{"key":"10.1016\/j.bbrc.2022.07.117_bib20","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.bbrc.2022.01.086","article-title":"Effects of a novel selective PPAR\u03b1 modulator, statin, sodium-glucose cotransporter 2 inhibitor, and combinatorial therapy on the liver and vasculature of medaka nonalcoholic steatohepatitis model","volume":"596","author":"Kimura","year":"2022","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2022.07.117_bib21","first-page":"55843","article-title":"Echocardiographic and histological examination of cardiac morphology in the mouse","volume":"128","author":"Baudouy","year":"2017","journal-title":"J.\u00a0Vis. Exp."},{"key":"10.1016\/j.bbrc.2022.07.117_bib22","first-page":"4995","article-title":"Image analysis of breast cancer immunohistochemistry-stained sections using ImageJ: an RGB-based model","volume":"29","author":"Vrekoussis","year":"2009","journal-title":"Anticancer Res."},{"key":"10.1016\/j.bbrc.2022.07.117_bib23","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.117.006040","article-title":"Interleukin 10 treatment ameliorates high-fat diet-induced inflammatory atrial remodeling and fibrillation","volume":"11","author":"Kondo","year":"2018","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"10.1016\/j.bbrc.2022.07.117_bib24","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s11010-016-2849-0","article-title":"Relevance of mouse models of cardiac fibrosis and hypertrophy in cardiac research","volume":"424","author":"Rai","year":"2017","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.bbrc.2022.07.117_bib25","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.bbrc.2014.08.109","article-title":"Ageing related periostin expression increase from cardiac fibroblasts promotes cardiomyocytes senescent","volume":"452","author":"Li","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2022.07.117_bib26","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.jhep.2020.01.013","article-title":"NAFLD as a driver of chronic kidney disease","volume":"72","author":"Byrne","year":"2020","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.bbrc.2022.07.117_bib27","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1002\/hep.26717","article-title":"Extrahepatic complications of nonalcoholic fatty liver disease","volume":"59","author":"Armstrong","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.bbrc.2022.07.117_bib28","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/s41575-018-0010-0","article-title":"Risk of cardiomyopathy and cardiac arrhythmias in patients with nonalcoholic fatty liver disease","volume":"15","author":"Anstee","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbrc.2022.07.117_bib29","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/labinvest.2016.65","article-title":"Hypoxia-stimulated cardiac fibroblast production of IL-6 promotes myocardial fibrosis via the TGF-\u03b21 signaling pathway","volume":"96","author":"Wang","year":"2016","journal-title":"Lab. Invest."},{"key":"10.1016\/j.bbrc.2022.07.117_bib30","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.cmet.2020.09.006","article-title":"Generation of a p16 reporter mouse and its use to characterize and target p16high cells in\u00a0vivo","volume":"32","author":"Omori","year":"2020","journal-title":"Cell Metabol."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X22011020?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X22011020?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T14:43:41Z","timestamp":1762094621000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X22011020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":30,"alternative-id":["S0006291X22011020"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2022.07.117","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of a selective PPAR\u03b1 modulator, sodium-glucose cotransporter 2 inhibitor, and statin on the myocardial morphology of medaka nonalcoholic fatty liver disease model","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2022.07.117","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}